Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Vial 5 ml x 200 mg |
|
3559 | 7861 |
|
Vial 25 ml x 1000 mg |
|
3560 | 7862 |
|
Vial 50 ml x 2000 mg |
|
3561 | 7863 |
Related information
Dosage
According to indication.
See prescribing information for full details.
Indications
Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.Treatment of patients with bladder cancer at the invasive stage.In combination with paclitaxel for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.In combination with carboplatin for the treatment of patients with recurrent epithelial ovarian carcinoma that has relapsed at least six months after platinum based therapy.
Contra-Indications
Hypersensitivity to gemcitabine, or to any of the constituents. Pregnancy, lactation.
See prescribing information for full details.
Special Precautions
See prescribing information for full details.
Side Effects
Nausea with or without vomiting, raised AST/ALT and alkaline phosphotases. Proteinuria and hematuria, dyspnea, allergic skin rashes.
See prescribing information for full details.
Drug interactions
See prescribing information for full details.
